Remove tag disease-modelling
article thumbnail

STAT+: CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies

STAT

In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. government on Tuesday announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments. million and $3.1 million and $3.1

135
135
article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more

STAT

In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments , STAT says.  Two million and $3.1

96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. While performance-based RSAs initially grew in popularity, ease of implementation allowed finance-based models to dominate. Countries with a high willingness for performance-based models, such as the UK, saw this RSA type peak in 2019 before continually declining.

FDA 105
article thumbnail

Predicting pandemics with unconventional digital tools

pharmaphorum

At this moment, people recognise that monitoring infectious diseases, in the US or globally, is challenging because data takes time. People get sick, the data goes into health records, the laboratory confirmations end up in Centers for Disease Control (CDC) and the ministries of health, and eventually with world bodies. Digital COVID.

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Flawed funding model. Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.